Skip to main content
Log in

Antidiabetic and antioxidant effect of Swietenia macrophylla seeds in experimental type 2 diabetic rats

  • Original Article
  • Published:
International Journal of Diabetes in Developing Countries Aims and scope Submit manuscript

Abstract

The detrimental effects of diabetic complications are mainly mediated through oxidative stress. Despite considerable progress in the treatment of diabetes by insulin and oral hypoglycemic agents, search for newer drugs continue. Many studies have been carried out in search of a suitable plant drug that would be effective in diabetes mellitus. The present investigation was undertaken to evaluate the effect of aqueous extract of Swietenia macrophylla seeds on blood glucose levels and oxidative stress in streptozotocin induced type 2 diabetic rats. The Albino rat (Wister Strain) weighing 200–250 g were divided into five groups of six rats each and streptozotocin was used to induce diabetes except in the control group. The control group (I) and diabetic control group (II) received redistilled water. Group III and V diabetic rats were administered with aqueous extract of Swietenia macrophylla seeds (2 gm/kg body weight) daily for 30 days. Peptide was mixed with extract as adjuvant in the latter group (1:1, 2 g / kg body weight/ day for 30 days). Group IV diabetic rats were fed with aqueous extract of established drug Metformin (10 mg/kg body weight). The oral administration of extract alone (2 g / kg body) and extract plus soya peptide (1:1, 2 g / kg body weight) per day for 30 days to diabetic rats was found to possess significant hypoglycemic activity. The antioxidant activity in the blood of Swietenia macrophylla seeds extract-treated diabetic rats and aqueous extract of Swietenia macrophylla seeds, estimated by modified FORD test and expressed as Torlox equivalents also revealed significant antioxidant activity. The present study demonstrates that the aqueous extract of Swietenia macrophylla seeds have substantial anti-diabetic and antioxidant properties. An extensive population based study is required in this direction, to establish this natural product as a therapeutic agent for diabetes mellitus.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Koya D, King GL. Protein kinase C: activation and the development of diabetic complications. Diabetes. 1998;47:859–66.

    Article  PubMed  CAS  Google Scholar 

  2. Pitozzi V, Giovannelli L, Bardini G, Rotella CM, Dolara A. Oxidative DNA damage in peripheral blood cells in type diabetes mellitus: higher vulnerability of polymorphonuclear leucocytes. Mutat Res. 2003;529:129–33.

    Article  PubMed  CAS  Google Scholar 

  3. Ceriello A. Oxidative stress and glycemic regulation. Metabolism. 2000;49:27–9.

    Article  PubMed  CAS  Google Scholar 

  4. Baynes JW. Role of oxidative stress in development of complications in diabetes. Diabetes. 1991;40:405–12.

    Article  PubMed  CAS  Google Scholar 

  5. Baynes JW, Thorpe SR. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes. 1999;48:1–9.

    Article  PubMed  CAS  Google Scholar 

  6. Dewanjee S, Das AK, Sahu R, Gangopahyay M. Antidiabetic activity of Diospyros peregrine fruit: effect on hyperglycemia, hyperlipidemia and augmented oxidative stress in experimental type 2 diabetes. Food Chem Toxicol. 2009;47:2679–85.

    Article  PubMed  CAS  Google Scholar 

  7. Knowler WC, Conner BE, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM. Reduction in the incidence of type 2 diabetes with life style intervention or metformin. N Eng J Med. 2002;346:393–403.

    Article  CAS  Google Scholar 

  8. Fontebonne A, Charles MA, Vague IJ, Bard JM, Andre P, Isnand F, Cohen JM, Motlet PG, Vague P, Safar ME, Eschoege E. The effect of metformin on the metabolic abnormalities associated with upper body fat distribution. BIGPRO Study Group. Diabetes Care. 1996;19:920–8.

    Article  Google Scholar 

  9. Chopra RN, Nayar SL, Chopra IC. Glossary of Indian medicinal plants. New Delhi: CSIR; 1956.

    Google Scholar 

  10. Bhattacharya S, Chirangeebee B. Dose-dependent effects of fenugreek composite in diabetes with dyslipidaemia. Internet J Food Saf. 2006;8:49–55.

    Google Scholar 

  11. Asolkar LV, Kakkar KK, Chakre OJ. Second supplement to glossary of India Medical plants with active principles. Part II & I. New Delhi: Council of Scintific & Industrial Research; 1992.

  12. Marles RJ, Farnsworth NR. Antidiabetic plants and their active constituents. Phytomedicine. 1995;2:137–89.

    Article  PubMed  CAS  Google Scholar 

  13. Prajapathi ND, Purohit SS, Sharma AK, Kumar T. A Handbook of medicinal plants-a complete source book. Agrobios; (India) Jodhpur; 2003. pp. 12.

  14. Sahgal G, Ramanathan S, Sasidharan S, Mordi MN, Ismail S, Mansor SM. In vitro antioxidant and xanthine oxidase inhibitory activities of methanolic Swietenia mahagoni seed extracts. Molecules. 2009;14:4476–85.

    Article  PubMed  CAS  Google Scholar 

  15. Chudnoff M. Tropical timbers of the world. Agric. Handbk. Washington, DC: USDA Forest Service; 1984. p. 464.

    Google Scholar 

  16. Francis JK. Swietenia mahagoni Jacq: West Indies mahogany. New Orleans: USDA Forest Service, Southern Forest Experiment Station; 1991. p. 7.

    Google Scholar 

  17. Solomon KA, Malathi R, Ranjan SS, Narasinhari S, Netajji M. Swietenine. Acta Cryst E. 2003;59:1519–21.

    Article  Google Scholar 

  18. Connolly JD, Crindle RM, Overton KH, Warnock WDC. Swietenolidee. Tetrahedron Lett. 1965;6:2937–40.

    Article  Google Scholar 

  19. Chan KC, Tang TS, Toh HT. Isolation of swietenolide diacetate from Swietenia Macrophylla. Phytochemistry. 1976;15:429–30.

    Article  CAS  Google Scholar 

  20. Mootoo BS, Ali A, Motilal R, Pingal R, Ramlal A. Limonoids from Swietenia Macrophylla. J Nat Prod. 1999;62:1514–7.

    Article  PubMed  CAS  Google Scholar 

  21. Dutta M, Raychaudhuri U, Chakraborty R, Maji D. Sub-chronic toxicity study of the seeds of Swietenia macrophylla in wister rats. Sci Cult. 2012;78:78–83.

    Google Scholar 

  22. Dutta M, Raychaudhuri U, Chakraborty R, Maji D. Role of diet and plants on diabetic patients -a critical appraisal. Sci Cult. 2011;77:115–22.

    Google Scholar 

  23. Public Health Service Policy on Human Care and Use of laboratory animals. Washington, DC: US, Department of Health and Human Dervices;1986. p. 20892. Available from: Office for Protection from Research Risks, Building 31, Room 4B09, NIII, Bethesda, MD 20892. Available from: http://grants.nih.gov/grants/olaw/olaw.htm. [Last accessed on 24 January 2011].

  24. Siddque M, Sun Y, Lin JC, Chien YW. Facilitated transdermal transport of insulin. J Pharm Sci. 1987;76:341–5.

    Article  Google Scholar 

  25. Karunanayake EH, Hearse DJ, Mellows G. The synthesis of 14C streptozotocinand its distribution and excretion in rat. Biochem J. 1974;142:673–85.

    PubMed  CAS  Google Scholar 

  26. Palmieri B, Sblendorio V. Oxidative stress tests: overview on reliability and use Part II. Eur Rev Med Pharmacol Sci. 2007;11:383–99.

    PubMed  CAS  Google Scholar 

  27. Pavlatou MG, Papastamataki M, Apostolakou F, Papassotiriou I, Tentolouris N. FORT and FORD: two simple and rapid assays in the evaluation of oxidative stress in patients with type 2 diabetes mellitus. Metabolism. 2009;58:1657–62.

    Article  PubMed  CAS  Google Scholar 

  28. Kaneto H, Nakatani Y, Miyatsuke T, Kawamori D, Matsnoka T, Matsutisa M, Kajimto Y, Hori M. Possible novel therapy for diabetes with cell-permable JNR- inhibitory peptide. Nat Med. 2004;10:1128–32.

    Google Scholar 

  29. Tiwari AK, Rao JM. Diabetes mellitus and multiple therapeutic approaches of phytochemicals: present status and future prospects. Curr Sci. 2002;83:30–8.

    CAS  Google Scholar 

  30. Eileen M, Bulger MD, Ronald V, Maier MD. Antioxidats in critical illness. Arch Surg. 2001;136:1201–7.

    Article  Google Scholar 

Download references

Acknowledgment

Authors thankfully acknowledge UGC CAS I for providing necessary facilities.

Conflicts of interest

The authors have declared that there is no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Utpal Raychaudhuri.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dutta, M., Biswas, U.K., Chakraborty, R. et al. Antidiabetic and antioxidant effect of Swietenia macrophylla seeds in experimental type 2 diabetic rats. Int J Diabetes Dev Ctries 33, 60–65 (2013). https://doi.org/10.1007/s13410-012-0109-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13410-012-0109-8

Keywords

Navigation